Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/05/2010EP2181708A1 Use of Valproate for reducing CHOP levels, particularly in a mammal having SCI
05/05/2010EP2181707A1 Combined use of an alpha-adrenergic receptor antagonist and an anti-muscarinic agent
05/05/2010EP2181706A2 Florfenicol esters for treating bacterial infections
05/05/2010EP2181705A1 Sustained-release formulation of gliclazide
05/05/2010EP2181704A2 Drug delivery from rapid gelling polymer composition
05/05/2010EP2181114A1 New drugs with anticholestatic activity
05/05/2010EP2181112A1 Triazolopyridine compounds and their use as ask inhibitors
05/05/2010EP2181111A1 Thiadiazinone derivatives
05/05/2010EP2181110A2 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
05/05/2010EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
05/05/2010EP2181105A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
05/05/2010EP2181104A1 Zearalenone macrolide derivatives and uses of the same
05/05/2010EP2181099A2 Crystalline forms of erlotinib hcl and formulations thereof
05/05/2010EP2181092A1 1,3-dihydroisoindole derivatives
05/05/2010EP2181091A2 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
05/05/2010EP2180899A2 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases
05/05/2010EP2180894A1 Methods of activating irs-1 and akt
05/05/2010EP2180893A2 Pharmaceutical compositions and methods for the treatment of cancer
05/05/2010EP2180891A2 Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same
05/05/2010EP2180890A1 Methods of inhibiting or suppressing cellular proliferation
05/05/2010EP2180889A1 Extracts with liver-x-receptor modulators, compounds and their use especially in weight control
05/05/2010EP2180887A2 Pharmaceutical preparations containing highly volatile silicones
05/05/2010EP2180883A1 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
05/05/2010EP2180880A2 Micelle encapsulation of therapeutic agents
05/05/2010EP2180879A1 Non-textile polymer compositions and methods
05/05/2010EP2180844A2 Sublingual fentanyl spray
05/05/2010EP2180788A1 Anti-inflammatory compounds and uses thereof
05/05/2010EP2180787A1 Nitrated-fatty acids modulation of type ii diabetes
05/05/2010EP2102204B1 New aminopyrrolo[1,2- a]indole et aminopyridazino[1,6-a]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same
05/05/2010EP1987001B1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
05/05/2010EP1957452B1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium
05/05/2010EP1948648B1 3-aryl-isoxazole-4-carbonyl-benzofurane derivatives
05/05/2010EP1891001B1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS
05/05/2010EP1734987B1 Interferon-beta for anti-virus therapy for respiratory diseases
05/05/2010EP1718290B1 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis
05/05/2010EP1713468B1 Anthelmintic composition
05/05/2010EP1691926B1 Phosphatase inhibitor sample collection system
05/05/2010EP1615914B1 Cgrp receptor antagonists
05/05/2010EP1572106B1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
05/05/2010EP1569929B1 Compounds and methods for the treatment or prevention of flavivirus infections
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1485081B1 Ibuprofen solution for hard shell capsules
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010EP1472240B1 Drechslera anole derivatives, method for the production and use thereof
05/05/2010EP1436278B1 A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
05/05/2010EP1421058B1 Processes for the production of alpha-difluoromethyl ornithine (dfmo)
05/05/2010EP1417206B1 Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
05/05/2010EP1411993B1 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
05/05/2010EP1390026B1 Treatment of hpv caused diseases
05/05/2010EP1328504B1 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
05/05/2010EP1326847B1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
05/05/2010EP1274414B1 Nasal administration of metoclopramide for the treatment of gastroparesis
05/05/2010EP1267894B1 Viscoelastics for use in middle ear surgery
05/05/2010EP1232157B1 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
05/05/2010EP1227803B1 compounds for inhibiting iapp-associated amyloid deposits
05/05/2010EP1167366B1 Amine derivatives
05/05/2010EP1166788B1 Remedies for joint diseases
05/05/2010EP1162976B1 16-phenoxy-lipoxin analogs for medical use
05/05/2010EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
05/05/2010EP1089969B1 Stable no-delivering compounds
05/05/2010EP0946185B2 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
05/05/2010CN1993132B Film coated tablet having plural coats
05/05/2010CN1993120B Arylacetic acids and related compounds for treatment of alzheimer's disease
05/05/2010CN1982327B Phytosterin compound and its use
05/05/2010CN1981044B Lipid encapsulated interfering RNA
05/05/2010CN1980949B New 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1
05/05/2010CN1964729B Composition for prevention and treatment of urinary incontinence
05/05/2010CN1964719B Use of loteprednol etabonate for the treatment of dry eye
05/05/2010CN1954812B Use of Edaravone
05/05/2010CN1953757B Composition for cleaning intestinal canal
05/05/2010CN1947767B Medicine for treating and preventing infantile mental retardation, and its preparation method
05/05/2010CN1939438B Chinese medicinal composition, its extract containing insect and its preparation
05/05/2010CN1935157B Medical stone emulsifiable paste for treating skin disease and its preparing method
05/05/2010CN1923282B Anti-cancer slow release injection comprising hormone drug
05/05/2010CN1921867B Nucleoside phosphonate derivatives useful in the treatment of HIV infections
05/05/2010CN1921829B Patch
05/05/2010CN1911219B Medicine composition, and its application
05/05/2010CN1910177B Substituted quinolines and their use as mycobacterial inhibitors
05/05/2010CN1907987B Entecavir acid addition salt, preparation method and use thereof
05/05/2010CN1903208B Adefovir dipivoxil oral disintegration tablets preparation method
05/05/2010CN1891229B Medicinal composition for preventing or treating metabolic syndrome
05/05/2010CN1889847B Package drink
05/05/2010CN1883493B Solid-state molecular dispersible preparation of pennogenin compound
05/05/2010CN1883443B A health buccal spray and method for preparing same
05/05/2010CN1878767B Azole-based kinase inhibitors
05/05/2010CN1875968B Application of anisodamine in preparation of smoking-stopping medicament
05/05/2010CN1863779B Novel indazole derivative
05/05/2010CN1861104B Inula flower extractive used to breat diabets mellitus and hyperlipidemia
05/05/2010CN1832925B New P2X7 receptor avtagonists and their use
05/05/2010CN1813740B Sublingual pellicles containing naloxone hydrochloride and preparing method thereof
05/05/2010CN1809353B Medicine for prevention of and treatment for arteriosclerosis and hypertension.
05/05/2010CN1807413B Carbazole sulfonamide derivative and its preparation method
05/05/2010CN1806857B Multilayer-coated stent for controlled drug release and manufacturing method thereof
05/05/2010CN1788730B Gel containing centella general glycoside and sodium hyaluronate for preparing drop and spray agent
05/05/2010CN1787820B Composition for improving cognition and memory
05/05/2010CN1774241B Oral drug delivery system comprising high viscosity liquid carrier materials
05/05/2010CN1764661B Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain.
05/05/2010CN1762390B Burn and boil medicine and its preparation method
05/05/2010CN1761461B Application of prostaglandin composition for treatment of premature ejaculation
05/05/2010CN1761450B Skin preparation for external use characterized by containing sugar derivative of a,a-trehalose